Stock Events

Stock Events

Search...

Alnylam Pharmaceuticals (DUL.XETRA) Q3 2025 Earnings

31JulConfirmed

Q3 2025

-0.48

-0.47

-0.46

-0.45

Details

Expected EPS

-0.4760716004

Actual EPS

-0.446556

Surprise EPS

0.03

Surprise Percent

+6.2%

Description

Alnylam Pharmaceuticals (DUL.XETRA) has reported earnings of -0.446556 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.